Literature DB >> 8570730

Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma.

Q Peng1, T Warloe, J Moan, H Heyerdahl, H B Steen, J M Nesland, K E Giercksky.   

Abstract

Microscopic fluorescence photometry incorporating a light-sensitive thermo-electrically cooled charge-coupled device (CCD) camera was employed to investigate the fluorescence distribution of 5-aminolevulinic acid (ALA)-induced porphyrins in 22 patients with a total number of 52 noduloulcerative basal cell carcinomas (BCC) after topical ALA application with or without dimethylsulfoxide (DMSO)/ethylenediaminetetraacetic acid (EDTA) or after intravenous administration of ALA. Both localization patterns and amounts of ALA-induced porphyrins in the BCC were studied. The ALA-induced porphyrins were localized only in the superficial layers of the noduloulcerative BCC lesions after topical application of 20% ALA alone for 3 h. However, both the penetration of ALA into deep lesions and the production of the ALA-induced porphyrin fluorescence were increased after topical administration of 20% ALA and 20% DMSO/4% EDTA for 3 h. Prior treatment with 99% DMSO for 15 min further enhanced the ALA penetration into the BCC lesions after topical application of the ALA/DMSO/EDTA mixture and produced more ALA-induced porphyrins by a factor of about three compared with those treated with ALA alone. The penetration of ALA into the deep BCC lesions could also be increased by prolonging the time of topical application of 20% ALA/4% EDTA to 29-48 h (without DMSO). Intravenous injection of ALA led to a more homogeneous distribution of the ALA-derived porphyrins in the whole noduloulcerative BCC lesions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8570730     DOI: 10.1111/j.1751-1097.1995.tb09154.x

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  17 in total

Review 1.  Photodynamic therapy: a review.

Authors:  J S McCaughan
Journal:  Drugs Aging       Date:  1999-07       Impact factor: 3.923

2.  Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy.

Authors:  Maria Bernadete Riemma Pierre; Eduardo Ricci; Antonio Cláudio Tedesco; Maria Vitória Lopes Badra Bentley
Journal:  Pharm Res       Date:  2006-01-01       Impact factor: 4.200

3.  Ferrochelatase Deficiency Abrogated the Enhancement of Aminolevulinic Acid-mediated Protoporphyrin IX by Iron Chelator Deferoxamine.

Authors:  Pratheeba Palasuberniam; Daniel Kraus; Matthew Mansi; Alexander Braun; Richard Howley; Kenneth A Myers; Bin Chen
Journal:  Photochem Photobiol       Date:  2019-03-15       Impact factor: 3.421

Review 4.  Photodynamic therapy of skin cancers: sensitizers, clinical studies and future directives.

Authors:  F S De Rosa; M V Bentley
Journal:  Pharm Res       Date:  2000-12       Impact factor: 4.200

5.  Combination of Sonodynamic and Photodynamic Therapy against Cancer Would Be Effective through Using a Regulated Size of Nanoparticles.

Authors:  N Miyoshi; S K Kundu; T Tuziuti; K Yasui; I Shimada; Y Ito
Journal:  Nanosci Nanoeng       Date:  2016-02

Review 6.  Beyond the margins: real-time detection of cancer using targeted fluorophores.

Authors:  Ray R Zhang; Alexandra B Schroeder; Joseph J Grudzinski; Eben L Rosenthal; Jason M Warram; Anatoly N Pinchuk; Kevin W Eliceiri; John S Kuo; Jamey P Weichert
Journal:  Nat Rev Clin Oncol       Date:  2017-01-17       Impact factor: 66.675

7.  Photodynamic therapy of virus-associated epithelial tumours of the face in organ transplant recipients.

Authors:  Peter Schleier; Peter Hyckel; Alexander Berndt; Hans-Peter Bode; Volker Albrecht; Winfried Hindermann; Hartwig Kosmehl; Witold Zenk; Dieter Schumann
Journal:  J Cancer Res Clin Oncol       Date:  2004-03-02       Impact factor: 4.553

8.  Poly(L-histidine)-tagged 5-aminolevulinic acid prodrugs: new photosensitizing precursors of protoporphyrin IX for photodynamic colon cancer therapy.

Authors:  Renjith P Johnson; Chung-Wook Chung; Young-Il Jeong; Dae Hwan Kang; Hongsuk Suh; Il Kim
Journal:  Int J Nanomedicine       Date:  2012-05-17

9.  Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study.

Authors:  N Lange; P Jichlinski; M Zellweger; M Forrer; A Marti; L Guillou; P Kucera; G Wagnières; H van den Bergh
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

10.  Topical application of ALA and ALA hexyl ester on a subcutaneous murine mammary adenocarcinoma: tissue distribution.

Authors:  C Perotti; A Casas; H Fukuda; P Sacca; A Batlle
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.